These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7954814)

  • 21. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ; Yan S; Herr KD; Wenner CE
    Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
    Nourse J; Firpo E; Flanagan WM; Coats S; Polyak K; Lee MH; Massague J; Crabtree GR; Roberts JM
    Nature; 1994 Dec; 372(6506):570-3. PubMed ID: 7990932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact inhibition-induced inactivation of the cyclin D-dependent kinase in rat fibroblast cell line, 3Y1.
    Kato A; Takahashi H; Takahashi Y; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():361-2. PubMed ID: 9209390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
    Loubat A; Rochet N; Turchi L; Rezzonico R; Far DF; Auberger P; Rossi B; Ponzio G
    Oncogene; 1999 Jun; 18(22):3324-33. PubMed ID: 10362353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS
    Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
    Diehl JA; Sherr CJ
    Mol Cell Biol; 1997 Dec; 17(12):7362-74. PubMed ID: 9372967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
    Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
    Taipale M; Tiihonen E; Heiskanen A; Laiho M
    Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
    Naderi S; Gützkow KB; Christoffersen J; Smeland EB; Blomhoff HK
    Eur J Immunol; 2000 Jun; 30(6):1757-68. PubMed ID: 10898514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C; Pratt MA
    Mol Endocrinol; 1997 Aug; 11(9):1191-202. PubMed ID: 9259311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).
    Mandal M; Bandyopadhyay D; Goepfert TM; Kumar R
    Oncogene; 1998 Jan; 16(2):217-25. PubMed ID: 9464540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.